Literature DB >> 814955

Topical chemoprophylaxis with silver sulphadiazine and silver nitrate chlorhexidine creams: emergence of sulphonamide-resistant Gram-negative bacilli.

E J Lowbury, J R Babb, K Bridges, D M Jackson.   

Abstract

Controlled trials of 0.5% silver nitrate compresses (SN), 1% silver sulphadiazine cream (SSD), and a cream containing 0.5% silver nitrate and 0.2% chlorhexidine digluconate (SNC) showed that all were comparably effective in protecting burns from infection. SN compresses were much less active against miscellaneous Gram-negative bacilli than the other preparations, and the mean morning and evening temperatures and respiration rates in the patients treated with SN compresses were higher then those of patients treated with SSD. Pseudomonas aeruginosa and Proteus spp, though rare in all groups, were less often found in the patients treated with SN compresses. Sulphonamide-resistant Gram-negative bacilli became predominant during the trial of SSD cream on extensive burns and the prophylactic effectiveness of that preparation was thus reduced in the later stages of the trial.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 814955      PMCID: PMC1638835          DOI: 10.1136/bmj.1.6008.493

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  10 in total

1.  Prophylactic chemotherapy for burns. Studies on the local and systemic use of combined therapy.

Authors:  J S CASON; E J LOWBURY
Journal:  Lancet       Date:  1960-09-03       Impact factor: 79.321

2.  Revised analysis of mortality due to burns.

Authors:  J P Bull
Journal:  Lancet       Date:  1971-11-20       Impact factor: 79.321

3.  Alternative forms of local treatment for burns.

Authors:  E J Lowbury; H A Lilly; J S Cason; D M Jackson; J P Bull; J W Davies; P M Ford
Journal:  Lancet       Date:  1971-11-20       Impact factor: 79.321

4.  Local chemoprophylaxis for burns with gentamicin and other agents.

Authors:  E J Lowbury; D M Jackson
Journal:  Lancet       Date:  1968-03-30       Impact factor: 79.321

5.  Mortality and infection in extensively burned patients treated with silver-nitrate compresses.

Authors:  J S Cason; E J Lowbury
Journal:  Lancet       Date:  1968-03-30       Impact factor: 79.321

6.  Antiseptic and aseptic prophylaxis for burns: use of silver nitrate and of isolators.

Authors:  J S Cason; D M Jackson; E J Lowbury; C R Ricketts
Journal:  Br Med J       Date:  1966-11-26

7.  Topical chemoprophylaxis for burns: trials of creams containing silver sulphadiazine and trimethoprim.

Authors:  E J Lowbury; D M Jackson; C R Ricketts; B Davis
Journal:  Injury       Date:  1971-07       Impact factor: 2.586

8.  The successful control of burn wound sepsis.

Authors:  R B Lindberg; J A Moncrief; W E Switzer; S E Order; W Mills
Journal:  J Trauma       Date:  1965-09

9.  Silver sulfadiazine--a new topical therapy for Pseudomonas in burns. Therapy of Pseudomonas infection in burns.

Authors:  C L Fox
Journal:  Arch Surg       Date:  1968-02

10.  Cetrimide-nalidixic acid agar as a selective medium for Speudomonas aeruginosa.

Authors:  H A Lilly; E J Lowbury
Journal:  J Med Microbiol       Date:  1972-02       Impact factor: 2.472

  10 in total
  7 in total

1.  Common bacterial infections in infancy and childhood. 4. Skin and wound infections.

Authors:  M I Marks
Journal:  Drugs       Date:  1978-09       Impact factor: 9.546

2.  Hearing half the message? A re-audit of the care of patients with acute asthma by emergency ambulance crews in London.

Authors:  H Snooks; M Halter; Y Palmer; H Booth; F Moore
Journal:  Qual Saf Health Care       Date:  2005-12

3.  Are systemic prophylactic antibiotics necessary for burns?

Authors:  J C Lawrence; A R Groves
Journal:  Ann R Coll Surg Engl       Date:  1983-07       Impact factor: 1.891

4.  McIndoe lecture, 1978. Burns: McIndoe's contribution and subsequent advances.

Authors:  D M Jackson
Journal:  Ann R Coll Surg Engl       Date:  1979-09       Impact factor: 1.891

5.  Strategies for typing and properties of epidemic methicillin-resistant Staphylococcus aureus.

Authors:  B Cookson; H Talsania; J Naidoo; I Phillips
Journal:  Eur J Clin Microbiol       Date:  1986-12       Impact factor: 3.267

6.  Drug resistance in relation to use of silver sulphadiazine cream in a burns unit.

Authors:  K Bridges; E J Lowbury
Journal:  J Clin Pathol       Date:  1977-02       Impact factor: 3.411

7.  Antimicrobial biocides in the healthcare environment: efficacy, usage, policies, and perceived problems.

Authors:  Jean-Yves Maillard
Journal:  Ther Clin Risk Manag       Date:  2005-12       Impact factor: 2.423

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.